Advice on using social media, texts and Skype to keep young people engaged in treatment for their diabetes has been published as part of wider information to help commissioners improve care transition. NHS England has produced a new service specification to help improve services for young people transferring from child to adult services or from one […]
NHS England has today published an interim clinical commissioning policy on the use of adalimumab for children with severe refractory uveitis, recommending its use for patients who meet the clinical criteria it sets out. This policy will benefit children for whom uveitis threatens their sight, and for whom other treatments have proven ineffective. A policy […]
NHS England has today (23 September 2015) published a six-monthly data report on patient safety incidents reported to the National Reporting and Learning System (NRLS) between 1 October 2014 and 31 March 2015. Acute hospitals, mental health services, community trusts, ambulance services and primary care organisations report incidents to the NRLS where any patient could have […]
The first centres to treat patients with stereotactic ablative radiotherapy (SABR), as part of NHS England’s latest national evaluation programme, will be able to start accepting patients from today (Monday). NHS England has invested £15m over three years to assess the use of SABR through its Commissioning through Evaluation initiative, which will allow up to […]
Since the publication of this blog John Young has left NHS England. NHS England’s National Clinical Director for the Frail Elderly and Integration invites us to change our perception of what frailty actually is: One of the widely acknowledged health triumphs is the remarkable and rapid increase in the life expectancy that occurred during the […]
NHS England has published an updated Cancer Drugs Fund (CDF) list following decisions, made by cancer doctors and patient representatives at the last national CDF panel meeting, that aim to deliver the maximum clinical benefit for patients. The updated CDF list reflects the outcomes of the appeals from pharmaceutical companies following the removal of drugs […]
The introduction of the access and waiting time standards for mental health marks the start of a new era in England’s mental health services and in its healthcare system. It is the start of the end of the low levels of access to effective care and treatments for so many people who live their lives in […]
A patient safety alert has been issued by NHS England to raise awareness of harm from using Low Molecular Weight Heparins (LMWHs) where a situation, patient’s condition, or the use of other medications mean the LMWHs could cause harm or death. Low Molecular Weight Heparins (LMWHs) are frequently used for treatment and to prevent a […]
A stage one warning has been issued to raise awareness of harm from using Low Molecular Weight Heparins (LMWHs) where a situation, patient’s condition, or the use of other medications mean the LMWHs could cause harm or death. Harm from using Low Molecular Weight Heparins when contraindicated Low Molecular Weight Heparins (LMWHs) are frequently used […]
The NHS Cancer Drugs Fund (CDF) today (Monday) published the outcome of its review of drugs included in the Fund. The budget for the CDF will grow from £200 million in 2013/14, to £280 million in 2014/15, and an estimated £340 million from April 2015. This represents a total increase of 70 per cent since […]